Medicxi Ventures Management’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71.6M | Hold |
|
|||||
|
2025
Q1 | $46.8M | Hold |
|
|||||
|
2024
Q4 | $60.6M | Hold |
|
|||||
|
2024
Q3 | $135M | Hold |
|
|||||
|
2024
Q2 | $76.9M | Hold |
|
|||||
|
2024
Q1 | $79.3M | Buy |
|
|||||
|
2023
Q4 | $34.3M | Hold |
|
|||||
|
2023
Q3 | $39M | Hold |
|
|||||
|
2023
Q2 | $53.9M | Buy |
|
|||||
|
2023
Q1 | $17.7M | Hold |
|
|||||
|
2022
Q4 | $27.9M | Hold |
|
|||||
|
2022
Q3 | $27.5M | Buy |
|
|||||
|
2022
Q2 | $20.7M | Buy |
|
|||||
|
2022
Q1 | $28.1M | Hold |
|
|||||
|
2021
Q4 | $40.7M | Hold |
|
|||||
|
2021
Q3 | $66.4M | Hold |
|
|||||
|
2021
Q2 | $70M | Hold |
|
|||||
|
2021
Q1 | $77.7M | Hold |
|
|||||
|
2020
Q4 | $68.7M | Hold |
|
|||||
|
2020
Q3 | $75.8M | Hold |
|
|||||
|
2020
Q2 | $68.1M | Hold |
|
|||||
|
2020
Q1 | $53.4M | Hold |
|
|||||
|
2019
Q4 | $64.4M | Buy |
|